Cantor Fitzgerald has a “Neutral” rating and a $100.00 price objective on the stock. The consensus estimate for Fortinet’s current full-year earnings is $2.09 per share. Get alerts: ...

Cantor Fitzgerald currently has a “Neutral” rating and a $100.00 target price on the stock. The consensus estimate for Fortinet’s current full-year earnings is $2.09 per share.

The staffing additions in Germany are also opportunistic. HAL is in the midst of being acquired by Dutch bank ABN Amro Bank NV in a deal announced in May 2024. The new hires, who will start at Cantor ...

Cantor Fitzgerald has reiterated its Overweight rating and $35.00 price target on Rocket Lab USA (NASDAQ: RKLB) stock following investor meetings across Europe last week. Currently trading at $25. ...

Docebo Inc. (NASDAQ:DCBO) is one of the 10 Best Small-Cap Growth Stocks to Buy According to Analysts. On June 9, analyst Yi Fu Lee from Cantor Fitzgerald initiated coverage on Docebo Inc. (NASDAQ ...

Cantor Fitzgerald has a “Overweight” rating and a $340.00 price target on the stock. The consensus estimate for Zscaler’s current full-year earnings is ($0.10) per share. Get alerts: ...

Zscaler, Inc. (NASDAQ:ZS) is one of the 10 Hot Large Cap Stocks to Buy Now. On June 11, Cantor Fitzgerald analyst Jonathan Ruykhaver raised the firm’s price target on Zscaler, Inc. (NASDAQ:ZS ...

The influx of traditional finance giants like Cantor Fitzgerald and banks into crypto lending is a net positive that will lower capital costs, but crypto-native lenders must leverage their ...

Rocket Lab Corporation (NASDAQ:RKLB) is among the best NASDAQ stocks under $50 to buy Analysts at Cantor Fitzgerald have reaffirmed their Overweight rating and $35.00 price target on Rocket Lab ...

Oracle Corporation (NYSE:ORCL) is one of the best wide moat stocks to buy now. On June 9, Cantor Fitzgerald analyst Thomas Blakey reiterated an Overweight rating on ORCL and assigned a price ...

Cantor Fitzgerald has a “Overweight” rating and a $2,700.00 price objective on the stock. The consensus estimate for MercadoLibre’s current full-year earnings is $43.96 per share.

Cantor Fitzgerald analyst S. Seedhouse expects that the biotechnology company will post earnings per share of ($4.01) for the year. Cantor Fitzgerald has a “Strong-Buy” rating on the stock.